John P. Rearick, Ph.D.
- +1 617 728 7193
- john.rearick@dechert.com
- vCard
-
Boston OfficeOne International Place, 40th Floor, 100 Oliver Street, Boston, MA, United States of America 02110-2605
Key Matters
Patent Prosecution and Counseling
- Celgene in a global portfolio covering covalent small molecule inhibitors in a crowded patent landscape, including claims to protein-inhibitor conjugates agnostic to inhibitor structure.
- Forma Therapeutics in executing a strategic series of patents filings to extend exclusivity period for phase II drug candidate.
- A large pharmaceutical company in procuring the first Orange Book listable patent for an already approved drug.
- A small pharmaceutical company on patent filing strategy for a small molecule series showing activity against multiple targets of clinical interest.
- Saudi Aramco in a European opposition and appeal involving defending a key patent on innovative polymers and challenging third party patent rights in foreign jurisdictions.
- Saudi Aramco in a patent invalidation trial and appeal in South Korea.
- A large pharmaceutical company in conducting extensive pre-ANDA litigation analysis of a newly approved drug.
- Underwriters and private companies in IP due diligence analyses and opinions in the context of initial public offerings.
- Forma Therapeutics as lead IP counsel in its US$278 million initial public offering.
Patent Trial and Appeal Board
- Valo Early Discovery, Inc. (f/k/a Integral Early Discovery, Inc.) in an appeal of a PTAB post-grant review decision involving a patent protecting novel inhibitors of ubiquitin-specific protease 7 (USP7).
- Progenics Pharmaceuticals, Inc. in a PGR proceeding challenging a patent directed to compounds for preparing 18F-radiolabeled Prostate-Specific Membrane Antigen (PSMA)-targeting conjugates.
- Forma Therapeutics, Inc. in a PGR proceeding defending a patent protecting novel inhibitors of ubiquitin-specific protease 7 (USP7).
- Saudi Arabian Oil Co. in an IPR proceeding challenging a patent directed to polycarbonates.
Includes matters handled at Dechert or prior to joining the firm.
- Rising Star – Massachusetts Super Lawyers
- Intellectual Property – Patents: Prosecution (Including Re-examination and Post-Grant Proceedings) – The Legal 500 US 2022
- Fully Exploiting Your Innovations: Best Practice in Innovation Harvesting – Moderator, Life Sciences Patent Network North America (May 2022)
- Patent Strategies in Light of Clinical Trial Disclosures – Moderator, Life Sciences Patent Network Live (October 2021)
- 1L Boot Camp: OCI Interviewing – Panelist, Boston College, Newton Centre (April 2019)
- Patents 101 – Presenter, Harvard University (December 2018)
- Translational Research in Biomaterials Seminar Series – Presenter, Boston University
- The Legal Profession: Explore Careers – Panelist, Harvard University
- Synthesis of Skeletally Diverse Small Molecules with Non-Natural Motifs: A Boronic Ester Annulation Strategy – Poster presentation, Broad Institute of Harvard and MIT Annual Meeting
- Synthesis of Skeletally Diverse Small Molecules with Non-Natural Motifs: A Boronic Ester Annulation Strategy – Speaker, HHMI Meeting of Predoctoral Fellows, Chevy Chase, Maryland
- Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydrox-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors – Co-author, Journal of Medicinal Chemistry
- Asymmetric Synthesis of Umuravumbolide – Co-author, Organic Letters
Services
Industries
-
- Purdue University, B.S., 2001
- Harvard University, A.M., 2004
- Harvard University, Ph.D., Chemistry, 2007
- Boston University School of Law, J.D., 2013
-
- Massachusetts
- United States Patent and Trademark Office
-
- PTAB Bar Association
- Boston Patent Law Association
- Massachusetts LGBTQ Bar Association